Related to this topic: Leaflets | Support | Weblinks | Equipment | Books | Your Experience | Other resources | Glossaries
Print options: Printer friendly version of this leaflet (html)     Other options:  AddThis Social Bookmark Button (what's this?)

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Oropharyngeal Tumours

The oropharynx includes the base of tongue, the inferior surface of the soft palate and uvula, the anterior and posterior tonsillar pillars, the glossotonsillar sulci, the pharyngeal tonsils, and the lateral and posterior pharyngeal walls. The borders of the oropharynx include the circumvallate papillae anteriorly, the plane of the superior surface of the soft palate superiorly, the plane of the hyoid bone inferiorly, the pharyngeal constrictors laterally and posteriorly, and the medial aspect of the mandible laterally.
In the reality of primary care it is not important to be so precise about the anatomy and large tumours may extend beyond this space. Of tumours of the oropharynx, 90% are squamous cell carcinomas. Other tumours include lymphoma and salivary gland tumours of the minor glands.

Epidemiology

It is a fairly uncommon malignancy with around 500 new cases a year and men are involved about 3 or 4 times as frequently as women.1

Risk factors

Smoking, heavy alcohol consumption and poor dentition are the principle risk factors in western countries.2 Several carcinogens, occupational exposures and vitamin deficiencies may also be involved.3

History

Presenting symptoms include:

  • Sore throat
  • Bleeding causing haemoptysis
  • Dysphagia
  • Pain referred to the ear
  • Changes in the voice
  • Trismus suggests involvement of the pterygoid musculature
  • Presentation may be the lump of a lymph node metastasis.
Examination:
  • A mass may be visible.
  • Palpate for nodes. Lymph node metastases generally occur in the upper jugular chain, although they can "skip" to lower levels and spread. Bilateral metastases are more common with tongue base and soft palate lesions, especially with midline lesions.
Investigations

Biopsy is essential for diagnosis. Imaging studies should focus on invasion through the pharyngeal constrictors, bony involvement of the pterygoid plates or mandible, invasion of the parapharyngeal space or carotid artery, involvement of the prevertebral fascia, and extension into the larynx.

Tumour staging

This is as for the oral cavity. Most tumours are irregular in shape and hence the term diameter refers to the maximum diameter.

Site
Stage
TNM Classification
Tumour Tx not defined
  T0 no primary tumour or carcinoma in situ
  T1 less than 2 cm diameter
  T2 tumour 2 to 4 cm diameter
  T3 tumour over 4 cm diameter
  T4 tumour invades surrounding structures
Nodes Nx lymph nodes cannot be assessed
  N0 no regional nodes involved
  N1 no regional nodes involved
  N2a single ipsilateral lymph node between 3 and 6 cm in diameter
  N2b multiple ipsilateral lymph nodes, none larger than 6 cm diameter
  N2c bilateral or contralateral lymph nodes, none larger than 6 cm diameter
  N3 lymph node larger than 6 cm in diameter
Metastasis Mx not assessed
  M0 no distant metastases
  M1 distant metastasis present

Management:
  • Treatment of oropharyngeal SCC increasingly moves towards chemotherapy and radiotherapy rather than surgery. Tumours are often poorly differentiated and respond well to radiotherapy. Chemotherapy may also function as a radiation sensitiser.
  • In recent studies, the local control rate has achieved 90% even in stage IV disease, although overall survival has not improved over more traditional surgery and radiation therapy.4
  • Surgery is necessary if the primary tumour involves the mandible and resectable recurrent disease and has a role in very early, superficial lesions that do not merit a full course of radiation.
  • Extensive surgery of the base of the tongue significantly alters the patient's ability to swallow. Reconstruction of the tongue with preservation of the larynx requires surgical techniques that maintain tongue mobility and suspend the larynx and neotongue to prevent aspiration.
Complications

Surgical resection or contracture after radiotherapy of the soft palate may result in velopharyngeal insufficiency (VPI). This causes nasal regurgitation of liquids and solids and hypernasal speech. Surgical augmentation of the soft palate can be performed or a palatal obturation may be used. A palatal obturator requires cleaning and is not permanent but patients are able to remove them during sleep. With surgical augmentation of the palate, the balance between reducing VPI and causing obstructive sleep apnoea is difficult. For patients who have had the base of the tongue resected, an inferiorly directed palatal obturator assists in achieving contact at the tongue base that is necessary for the projection of food posteriorly during the oral and pharyngeal phases of swallowing. There may be less problems with swallowing after chemotherapy than with surgery and radiotherapy.5

Prognosis

The optimum balance between the various treatments needs to be ascertained.6,7 Survival figures can be remarkably good but should be interpreted with caution for any single case with such a varied group of conditions.


Document References
  1. ONS; Cancer Statistics 2003 {As PDF]
  2. Graham S, Dayal H, Rohrer T, et al; Dentition, diet, tobacco, and alcohol in the epidemiology of oral cancer.; J Natl Cancer Inst. 1977 Dec;59(6):1611-8. [abstract]
  3. Licitra L, Bernier J, Grandi C, et al; Cancer of the oropharynx.; Crit Rev Oncol Hematol. 2002 Jan;41(1):107-22. [abstract]
  4. Adelstein DJ, Saxton JP, Lavertu P, et al; Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer With hyperfractionated radiation and concurrent chemotherapy.; J Clin Oncol. 2002 Mar 1;20(5):1405-10. [abstract]
  5. Gillespie MB, Brodsky MB, Day TA, et al; Swallowing-related quality of life after head and neck cancer treatment.; Laryngoscope. 2004 Aug;114(8):1362-7. [abstract]
  6. Adelstein DJ; Oropharyngeal cancer: the role of chemotherapy.; Curr Treat Options Oncol. 2003 Feb;4(1):3-13. [abstract]
  7. Kovacs AF; Maximized combined modality treatment of an unselected population of oral and oropharyngeal cancer patients. Final results of a pilot study compared with a treatment-dependent prognosis index.; J Craniomaxillofac Surg. 2006 Mar;34(2):74-84. Epub 2006 Jan 19. [abstract]

Internet and Further Reading
  • Saghedi N; Malignant tumors of the palate; eMedicine; July 2005. Also contains good pictures.
  • Lorenz RR et al; Textbook of Surgery Ch. VI - Elsevier (on line) [As PDF]
  • Cancer Research UK; Treatment options for mouth cancer
Acknowledgements EMIS is grateful to the Mentor authoring team for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2007.
DocID: 1575
Document Version: 20
DocRef: bgp975
Last Updated: 12 Sep 2006
Review Date: 11 Sep 2008




















Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site










Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site


PS - Health and Poverty

Perhaps the biggest cause of ill health in the world is poverty. Help to Make Poverty History. For example, why not lend some of your money to disadvantaged communities to enable them to trade their way out of poverty through schemes such as Shared Interest.

See also MAKEPOVERTYHISTORY North East for details and links to campaigns against poverty.

^ Top of Page